BCI
IBB icon

Brinker Capital Investments’s iShares Biotechnology ETF IBB Stock Holding History

Brinker Capital Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,551
Closed -$262K – 2131
2025
Q4 		$262K Buy
1,551
+139
+10% +$22.6K ﹤0.01% 1873
2025
Q3 		$204K Buy
+1,412
New +$193K ﹤0.01% 1963
2025
Q1 		– Sell
-1,767
Closed -$234K – 1921
2024
Q4 		$234K Sell
1,767
-44
-2% -$6.19K ﹤0.01% 1678
2024
Q3 		$264K Sell
1,811
-105
-5% -$15.2K ﹤0.01% 1583
2024
Q2 		$263K Buy
+1,916
New +$256K ﹤0.01% 1511
2023
Q2 		– Sell
-1,774
Closed -$229K – 1647
2023
Q1 		$229K Buy
+1,774
New +$232K ﹤0.01% 1452
2022
Q2 		– Sell
-2,556
Closed -$333K – 1373
2022
Q1 		$333K Buy
2,556
+1,223
+92% +$159K 0.01% 1184
2021
Q4 		$203K Buy
+1,333
New +$206K ﹤0.01% 1350
2021
Q2 		– Sell
-33,152
Closed -$4.99M – 1338
2021
Q1 		$4.99M Sell
33,152
-33,072
-50% -$5.25M 0.07% 268
2020
Q4 		$10M Buy
66,224
+32,773
+98% +$4.68M 0.16% 145
2020
Q3 		$4.53M Buy
+33,451
New +$4.54M 0.08% 261
2019
Q2 		– Sell
-57,500
Closed -$6.43M – 946
2019
Q1 		$6.43M Hold
57,500
– – 0.21% 105
2018
Q4 		$5.54M Buy
57,500
+57,419
+70,888% +$6.09M 0.19% 113
2018
Q3 		$10K Sell
81
-55,500
-100% -$6.54M ﹤0.01% 479
2018
Q2 		$6.1M Hold
55,581
– – 0.2% 112
2018
Q1 		$5.93M Hold
55,581
– – 0.19% 115
2017
Q4 		$5.93M Buy
55,581
+18,000
+48% +$1.92M 0.2% 106
2017
Q3 		$4.18M Buy
37,581
+81
+0.2% +$8.66K 0.15% 122
2017
Q2 		$3.88M Buy
37,500
+4,500
+14% +$443K 0.15% 124
2017
Q1 		$3.23M Buy
+33,000
New +$3.16M 0.13% 125

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Brinker Capital Investments's IBB Position: Q1 2026 in Review

Brinker Capital Investments sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 1,551 shares — an estimated $262K sold.

Brinker Capital Investments first reported a position in IBB in Q1 2017 and held it in 20 quarters. The position peaked at $10M in Q4 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Brinker Capital Investments reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Brinker Capital Investments sold 1,551 iShares Biotechnology ETF shares in Q1 2026, an estimated $262K.
  • Brinker Capital Investments first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 20 quarters.
  • Brinker Capital Investments's iShares Biotechnology ETF position peaked at $10M in Q4 2020.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.